Lum Alexa, Brady Mitchell
Dermatology, Michigan State University College of Osteopathic Medicine, East Lansing, USA.
Dermatology, Corewell Health Farmington Hills Hospital, Farmington Hills, USA.
Cureus. 2024 Dec 13;16(12):e75639. doi: 10.7759/cureus.75639. eCollection 2024 Dec.
Dyshidrosiform bullous pemphigoid (DBP) is a rare variant of bullous pemphigoid (BP) that mainly affects elderly patients and presents with tense bullae formation on the palms, soles, or both palms and soles. This case report describes an 87-year-old woman who was evaluated in the hospital for a month-long erythematous and pruritic rash on most of her body that eventually manifested into tense blisters on the palms. DBP can pose a challenge to clinicians as it can resemble a variety of different vesicular diseases. Therefore, clinical suspicion, as well as confirmatory testing with direct immunofluorescence (DIF), can aid clinicians in making a diagnosis of DBP. The mainstay of treatment is oral corticosteroids plus an immunosuppressant, but some monoclonal antibodies have shown promising efficacy in the treatment of more refractory cases of DBP. Additional research that focuses on the role of these monoclonal antibodies in the treatment of DBP is needed to determine their therapeutic benefit.
汗疱疹样大疱性类天疱疮(DBP)是大疱性类天疱疮(BP)的一种罕见变体,主要影响老年患者,表现为手掌、足底或手掌和足底均出现紧张性水疱。本病例报告描述了一名87岁女性,她因全身大部分部位出现为期一个月的红斑和瘙痒性皮疹而入院评估,最终手掌出现紧张性水疱。DBP可能给临床医生带来挑战,因为它可能类似于多种不同的水疱性疾病。因此,临床怀疑以及直接免疫荧光(DIF)的确诊检测有助于临床医生诊断DBP。治疗的主要方法是口服糖皮质激素加免疫抑制剂,但一些单克隆抗体在治疗更难治的DBP病例中已显示出有前景的疗效。需要更多关注这些单克隆抗体在DBP治疗中作用的研究,以确定它们的治疗益处。